Table 1 Clinical and pathological data in the study
| Â | pCR | Non-pCR | P-value |
|---|---|---|---|
No. of patients | 17 | 38 | N/A |
Age(y) | |||
 Median(range) | 50 (37–70) | 48 (25–68) | N/A |
 Mean ± SD | 50.7 ± 9.4 | 49.5 ± 10.4 | 0.676 |
Enhancement Type, No. (%) | Â | Â | 0.506 |
 Masslike | 11 (64.7) | 23 (60.5) |  |
 Non-masslike | 6 (35.3) | 15 (39.5) |  |
Max-D(cm)* | |||
 Median(range) | 2.6 (2.3–3.7) | 4.2 (3.1–5.4) | N/A |
 Mean ± SD | 2.9 ± 1.1 | 4.3 ± 1.9 | 0.002 |
Subtype, No. (%) | Â | Â | 0.493 |
 Luminal A | 5 (29.4) | 17 (44.7) |  |
 Luminal B | 2 (11.8) | 7 (18.4) |  |
 Her-2 | 5 (29.4) | 8 (21.1) |  |
 TNBC | 5 (29.4) | 6 (15.8) |  |
Regimen, No. (%) | Â | Â | 0.412 |
 EC + Taxol | 4 (23.5) | 14 (36.8) |  |
 FEC + Taxol | 7 (41.2) | 15 (39.5) |  |
 AC+ Taxol | 2 (11.8) | 6 (15.8) |  |
 Others | 4 (23.5) | 3 (7.9) |  |